Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles

Clinical Chemistry

Volumn 43, Issue 7, 1997, Pages 1129-1141

  Rashed, Mohamed S ^a   Bucknall, Martin P ^a   Little, Douglas ^a   Awad, Amin ^a   Jacob, Minnie ^a   Alamoudi, Mohamed ^a   Alwattar, Mona ^a   Ozand, Pinar T ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Amino acids; Defects of fatty acid oxidation; Inherited disorders; Neonatal screening; Organic acidemia

Indexed keywords

ACYLCARNITINE; AMINO ACID;

ALGORITHM; AMINO ACID METABOLISM; AMINOACIDEMIA; ARTICLE; BLOOD SAMPLING; COMPUTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INBORN ERROR OF METABOLISM; LABORATORY AUTOMATION; NEWBORN; NEWBORN SCREENING; PRACTICE GUIDELINE; REFERENCE VALUE; TANDEM MASS SPECTROMETRY;

EID: 0030751763     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.7.1129     Document Type: Article

References (42)

1. Ozand PT, Devol EB, Generoso GG. Neurometabolic diseases at a national referral center: five years experience at the King Faisal Specialist Hospital and Research Centre. J Child Neurol 1992; 7(Suppl):S4-S11.
2. Moammar H, Ratard R, Cheriyan G, Mathew P. Incidence and features of galactosemia in Saudi Arabs. J Inher Metab Dis 1996;19:331-4.
3. Teebi A. Autosomal recessive disorders among Arabs: an overview from Kuwait. J Med Genet 1994;31:224-33.
4. Temtamy SA, Kandil MR, Demerdash AM, Hassan WA, Meguid NA, Afifi HH. An epidemiological/genetic study of mental subnormality in Assiut Governorate, Egypt. Clin Genet 1994;46:347-51.
5. Arn PH, Valle DL, Brusilow SW. Inborn errors of metabolism: not rare, not hopeless. Contemp Pediatr 1988;5:47-63.
6. Ward JC. Inborn errors of metabolism of acute onset in infancy. Pediatr Rev 1990;11:205-16.
7. Goodman SI. Inherited metabolic disorders in the newborn: approach to diagnosis and treatment. Adv Pediatr 1986;33:197-224.
8. Leonard JV. The early detection and management of inborn errors presenting in the neonatal period. Eur J Pediatr 1985;143:253-7.
9. Seashore MR, Rinaldo P. Metabolic disease of the neonate and young infant. Semin Perinatol 1993;17:318-29.
10. Seashore MR. Neonatal screening for inborn errors of metabolism: update. Semin Perinatol 1990;14:431-8.
11. Scriver CR. Genetic screening, testing and treatment: how far can we go? J Inher Metab Dis 1996;19:401-11.
12. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-43.
13. Guthrie R. Screening for "inborn errors of metabolism" in the newborn infant - a multiple test program. Birth Defects 1968;4: 92-8.
14. Turnell DC, Cooper JDH. Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. Clin Chem 1982;28:527-31.
15. van Eijk HMH, van der Heijden MAH, van Berlo CLH, Soeters PB. Fully automated liquid-chromatographic determination of amino acids. Clin Chem 1988;34:2510-3.
16. Bremer J. Carnitine - metabolism, functions. Physiol Rev 1983; 63:1420-80.
17. Stanley CA. Carnitine disorders. Adv Pediatr 1995;42:209-42.
18. Chalmers RA, Roe CR, Stacey TE, Hoppel CL. Urinary excretion of L-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of L-carnitine. Pediatr Res 1984;18:1325-8.
19. Bhuiyan AKMJ, Jackson S, Turnbull DM, Aynsley-Green A, Leonard JV, Barlett K. The measurement of carnitine and acylcarnitines: application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxidation. Clin Chim Acta 1992;207:185-204.
20. Minkler PE, Hoppel CL. Quantification of free carnitine, individual short- and medium-chain acylcarnitines, and total carnitine in plasma by high-performance liquid chromatography. Anal Biochem 1993;212:510-8.
21. Schmidt-Sommerfeld E, Penn D, Duran M, Bennett MJ, Santer R, Stanley CA. Detection of inborn errors of fatty acid oxidation from acylcarnitine analysis of plasma and blood spots with the radioisotopic exchange-high-performance liquid chromatographic method. J Pediatr 1993;122:708-13.
22. Kodo N, Millington DS, Norwood DL, Roe CR. Automated analysis of free and short-chain acylcarnitine in plasma with a centrifugal analyzer. Clin Chem 1992;38:2215-21.
23. Van Bocxlaer JF, De Leenheer AP. Solid-phase extraction technique for gas chromatographic profiling of acylcarnitines. Clin Chem 1993;39:1911-7.
24. Lowes S, Rose ME, Mills GA, Pollitt RJ. Identification of urinary acylcarnitines using gas chromatography-mass spectrometry: preliminary clinical applications. J Chromatogr 1992;577:205-14.
25. Minkler PE, Hoppel CL. Quantification of carnitine and specific acylcarnitines by high-performance liquid chromatography: application to normal human urine and urine from patients with methylmalonic aciduria, isovaleric acidemia or medium-chain acyl-CoA dehydrogenase deficiency. J Chromatogr 1993;613:203-21.
26. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inher Metab Dis 1990;13:321-4.
27. Millington DS, Kodo N, Terada N, Roe CR, Chace DH. The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry. Int J Mass Spectrom Ion Processes 1991; 111:211-28.
28. Millington DS, Terada N, Chace DH, Chen Y, Ding J, Kodo N, et al. New developments in fatty acid oxidation. In: Coates PM, Tanaka K, eds. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. New York: Wiley-Liss, 1992:339-54.
29. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 1993;38:66-71.
30. Chace DH, Hillman SL, Millington DS, Kahler SG, Roe CR, Naylor EW. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. Clin Chem 1995; 41:62-8.
31. Chace DH, Hillman SL, Millington DS, Kahler SG, Adam BW, Levy HL. Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry. Clin Chem 1996;42:349-55.
32. Rashed MS, Ozand PT, Harrison ME, Watkins PJF, Evans S. Electrospray tandem mass spectrometry in the diagnosis of organic acidemias. Rapid Commun Mass Spectrom 1994;8:129-33.
33. Rashed MS, Ozand PT, Bucknall MP, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38:324-31.
34. Attia N, Sakati N, Al Ashwal A, Alsaif R, Rashed M, Ozand PT. Isovaleric acidemia appearing as diabetic ketoacidosis. J Inher Metab Dis 1996;19:85-6.
35. Shigematsu Y, Hata I, Nakai A, Kikawa Y, Sudo M, Tanaka Y, et al. Prenatal diagnosis of organic acidemias based on amniotic fluid levels of acylcarnitines. Pediatr Res 1996;39:680-4.
36. Rashed MS, Ozand PT, Bennett MJ, Barnard JJ, Govindarju DR, Rinaldo P. Inborn errors of metabolism diagnosed in sudden infant death cases by acylcarnitine analysis of postmortem bile. Clin Chem 1995;41:1109-14.
37. Hamosh A, Johnston MV, Valle D. Nonketotic hyperglycinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill, 1995:1337-48.
38. Solberg HE. Establishment and use of reference values. In: Burtis CA, Ashwood ER, eds. Tietz fundamentals of clinical chemistry. Philadelphia: WB Saunders, 1996:182-91.
39. Scott PH, Sandham S, Balmer SE, Wharton BA. Diet-related reference values for plasma amino acids in newborns measured by reversed-phase HPLC. Clin Chem 1990;36:1922-7.
40. Caruso U, Cerone R, Fantasia AR, Schiaffino MC, Zignego G, Romano C. Plasma amino acids during the first 24 h of life: feasibility of early diagnosis in the newborn at risk of amino acid disorders. J Inher Metab Dis 1989;12(Suppl):311-4.
41. Van Hove JLK, Zhang W, Kahler SG, Roe CR, Chen Y, Terada N, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet 1993;52:958-66.
42. Ziadeh R, Hoffman EP, Finegold DN, Hoop RC, Brackett JC, Strauss AW, et al. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res 1995;37: 675-8.